TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: STOPFLU: Is it Possible to Reduce the Number of Days Off in Office Work by Improved Hand-hygiene?
Brief Summary: Improved hand hygiene is known to reduce transmission of both respiratory (RTI) and gastrointestinal infections (GTI) under "semi-closed" conditions such as hospitals, day-care centres and schools. It is not known if similar interventions would have the desired effect in a regular office work. This study is aiming to investigate this possibility by recruiting volunteers from several companies in the Helsinki Region. The two intervention groups will receive detailed instructions e.g. for proper coughing and sneezing, and for regular cleaning of hands with either standard liquid soap or with alcohol-based gel rubbing. Third group will serve as the control and is advised not to change their previous behaviour in this respect. The participants will report weekly possible RTI or GTI symptoms and related days off through internet. The study is planned to run about 18 months to cover the seasonal variation of the epidemics of the causative different viruses.


Options:
A: Intervention Type: PROCEDURE; Name: Laparotomy+ HIPEC +/- CRS; Assigned to Arm(s): N/A
B: Arm Label: Hand washing; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Hand washing | Arm Label: Disinfectant rubbing; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Disinfectant rubbing | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Hand washing; Assigned to Arm(s): Hand washing | Intervention Type: BEHAVIORAL; Name: Disinfectant rubbing; Assigned to Arm(s): Disinfectant rubbing
C: Arm Label: No treatment; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 3804-250A lotion; Type: EXPERIMENTAL; Interventions: Drug: 3804-250A | Intervention Type: DRUG; Name: 3804-250A; Assigned to Arm(s): 3804-250A lotion
D: Arm Label: Hand sanitizer group; Type: EXPERIMENTAL; Interventions: Other: hand sanitizer | Arm Label: Liquid soap group; Type: EXPERIMENTAL; Interventions: Other: liquid soap | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: hand sanitizer; Assigned to Arm(s): Hand sanitizer group | Intervention Type: OTHER; Name: liquid soap; Assigned to Arm(s): Liquid soap group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: STOPFLU: Is it Possible to Reduce the Number of Days Off in Office Work by Improved Hand-hygiene?
Brief Summary: Improved hand hygiene is known to reduce transmission of both respiratory (RTI) and gastrointestinal infections (GTI) under "semi-closed" conditions such as hospitals, day-care centres and schools. It is not known if similar interventions would have the desired effect in a regular office work. This study is aiming to investigate this possibility by recruiting volunteers from several companies in the Helsinki Region. The two intervention groups will receive detailed instructions e.g. for proper coughing and sneezing, and for regular cleaning of hands with either standard liquid soap or with alcohol-based gel rubbing. Third group will serve as the control and is advised not to change their previous behaviour in this respect. The participants will report weekly possible RTI or GTI symptoms and related days off through internet. The study is planned to run about 18 months to cover the seasonal variation of the epidemics of the causative different viruses.


Options:
A: Arm Label: Normal recommendations, no mask; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Normal recommendations AND mask; Type: EXPERIMENTAL; Interventions: Other: Surgical facial mask | Intervention Type: OTHER; Name: Surgical facial mask; Assigned to Arm(s): Normal recommendations AND mask
B: Arm Label: No treatment; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 3804-250A lotion; Type: EXPERIMENTAL; Interventions: Drug: 3804-250A | Intervention Type: DRUG; Name: 3804-250A; Assigned to Arm(s): 3804-250A lotion
C: Arm Label: 1; Type: OTHER; Interventions: Other: Control | Arm Label: 2; Type: OTHER; Interventions: Device: Masks | Arm Label: 3; Type: OTHER; Interventions: Device: Masks & hand hygiene | Intervention Type: DEVICE; Name: Masks; Assigned to Arm(s): 2 | Intervention Type: DEVICE; Name: Masks & hand hygiene; Assigned to Arm(s): 3 | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): 1
D: Arm Label: Hand washing; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Hand washing | Arm Label: Disinfectant rubbing; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Disinfectant rubbing | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Hand washing; Assigned to Arm(s): Hand washing | Intervention Type: BEHAVIORAL; Name: Disinfectant rubbing; Assigned to Arm(s): Disinfectant rubbing

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: STOPFLU: Is it Possible to Reduce the Number of Days Off in Office Work by Improved Hand-hygiene?
Brief Summary: Improved hand hygiene is known to reduce transmission of both respiratory (RTI) and gastrointestinal infections (GTI) under "semi-closed" conditions such as hospitals, day-care centres and schools. It is not known if similar interventions would have the desired effect in a regular office work. This study is aiming to investigate this possibility by recruiting volunteers from several companies in the Helsinki Region. The two intervention groups will receive detailed instructions e.g. for proper coughing and sneezing, and for regular cleaning of hands with either standard liquid soap or with alcohol-based gel rubbing. Third group will serve as the control and is advised not to change their previous behaviour in this respect. The participants will report weekly possible RTI or GTI symptoms and related days off through internet. The study is planned to run about 18 months to cover the seasonal variation of the epidemics of the causative different viruses.


Options:
A: Arm Label: Sanitation intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Provision of household latrines | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Provision of household latrines; Assigned to Arm(s): Sanitation intervention
B: Arm Label: Classic Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Classic Intervention | Arm Label: Minimum Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Minimum Intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Classic Intervention; Assigned to Arm(s): Classic Intervention | Intervention Type: BEHAVIORAL; Name: Minimum Intervention; Assigned to Arm(s): Minimum Intervention
C: Arm Label: Hope Soap group; Type: EXPERIMENTAL; Interventions: Combination Product: Hope Soap | Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Combination Product: Control group soap | Intervention Type: COMBINATION_PRODUCT; Name: Hope Soap; Assigned to Arm(s): Hope Soap group | Intervention Type: COMBINATION_PRODUCT; Name: Control group soap; Assigned to Arm(s): Control group
D: Arm Label: Hand washing; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Hand washing | Arm Label: Disinfectant rubbing; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Disinfectant rubbing | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Hand washing; Assigned to Arm(s): Hand washing | Intervention Type: BEHAVIORAL; Name: Disinfectant rubbing; Assigned to Arm(s): Disinfectant rubbing

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: STOPFLU: Is it Possible to Reduce the Number of Days Off in Office Work by Improved Hand-hygiene?
Brief Summary: Improved hand hygiene is known to reduce transmission of both respiratory (RTI) and gastrointestinal infections (GTI) under "semi-closed" conditions such as hospitals, day-care centres and schools. It is not known if similar interventions would have the desired effect in a regular office work. This study is aiming to investigate this possibility by recruiting volunteers from several companies in the Helsinki Region. The two intervention groups will receive detailed instructions e.g. for proper coughing and sneezing, and for regular cleaning of hands with either standard liquid soap or with alcohol-based gel rubbing. Third group will serve as the control and is advised not to change their previous behaviour in this respect. The participants will report weekly possible RTI or GTI symptoms and related days off through internet. The study is planned to run about 18 months to cover the seasonal variation of the epidemics of the causative different viruses.


Options:
A: Arm Label: Facemask and hand hygiene; Type: EXPERIMENTAL; Interventions: Behavioral: Ear Loop Procedure Mask, Behavioral: 62% Ethyl Alcohol Hand Sanitizer | Arm Label: Facemask only; Type: EXPERIMENTAL; Interventions: Behavioral: Ear Loop Procedure Mask | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Ear Loop Procedure Mask; Assigned to Arm(s): Facemask and hand hygiene, Facemask only | Intervention Type: BEHAVIORAL; Name: 62% Ethyl Alcohol Hand Sanitizer; Assigned to Arm(s): Facemask and hand hygiene
B: Arm Label: Hand washing; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Hand washing | Arm Label: Disinfectant rubbing; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Disinfectant rubbing | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Hand washing; Assigned to Arm(s): Hand washing | Intervention Type: BEHAVIORAL; Name: Disinfectant rubbing; Assigned to Arm(s): Disinfectant rubbing
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Alcohol-based hand sanitizer & quaternary ammonium wipes | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Alcohol-based hand sanitizer & quaternary ammonium wipes; Assigned to Arm(s): 1
D: Intervention Type: PROCEDURE; Name: Laparotomy+ HIPEC +/- CRS; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Telemedicine Outreach for Post Traumatic Stress in CBOCs
Brief Summary: The purpose of this study is improved outcomes for veterans with Post Traumatic Stress Disorder (PTSD) treated in small VA Community Based Outpatient Clinics (CBOCs). Although psychotherapy and pharmacotherapy treatments for PTSD have been proven to be efficacious in controlled trials, geographic barriers often prevent veterans from accessing these evidence-based treatments. Telemedicine technologies will be used to overcome geographic barriers to care. Specifically, we will evaluate the Telemedicine Outreach for PTSD (TOP) intervention which is based on the principals of the Chronic Care Model and Disease Management, and builds on the evidence base of quality improvement for depression in primary care settings. The TOP intervention will employ an off-site PTSD care team (tele-psychiatrist, tele-psychologist, tele-pharmacist, and tele-nurse care manager) and will use telemedicine technologies (telephone, interactive video and electronically shared medical records) to treat CBOC patients with a newly emerging or chronic PTSD. We hypothesize that study participants randomized to the TOP intervention will receive higher quality of care and experience better outcomes compared to study participants randomized to treatment as usual.


Options:
A: Arm Label: Arm 1 Telemedicine Outreach for PTSD; Type: EXPERIMENTAL; Interventions: Other: Telemedicine Outreach for PTSD | Arm Label: Arm 2 Treatment as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Telemedicine Outreach for PTSD; Assigned to Arm(s): Arm 1 Telemedicine Outreach for PTSD
B: Arm Label: Arm 1; Type: OTHER; Interventions: Procedure: System level depression care quality improvement | Intervention Type: PROCEDURE; Name: System level depression care quality improvement; Assigned to Arm(s): Arm 1
C: Arm Label: Collaborative depression care; Type: EXPERIMENTAL; Interventions: Behavioral: Collaborative depression care management | Intervention Type: BEHAVIORAL; Name: Collaborative depression care management; Assigned to Arm(s): Collaborative depression care
D: Arm Label: CALM Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive-behavioral therapy, Drug: Psychotropic medication optimization | Arm Label: Treatment as Usual (TAU); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment as Usual | Intervention Type: BEHAVIORAL; Name: Cognitive-behavioral therapy; Assigned to Arm(s): CALM Intervention | Intervention Type: DRUG; Name: Psychotropic medication optimization; Assigned to Arm(s): CALM Intervention | Intervention Type: BEHAVIORAL; Name: Treatment as Usual; Assigned to Arm(s): Treatment as Usual (TAU)

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Telemedicine Outreach for Post Traumatic Stress in CBOCs
Brief Summary: The purpose of this study is improved outcomes for veterans with Post Traumatic Stress Disorder (PTSD) treated in small VA Community Based Outpatient Clinics (CBOCs). Although psychotherapy and pharmacotherapy treatments for PTSD have been proven to be efficacious in controlled trials, geographic barriers often prevent veterans from accessing these evidence-based treatments. Telemedicine technologies will be used to overcome geographic barriers to care. Specifically, we will evaluate the Telemedicine Outreach for PTSD (TOP) intervention which is based on the principals of the Chronic Care Model and Disease Management, and builds on the evidence base of quality improvement for depression in primary care settings. The TOP intervention will employ an off-site PTSD care team (tele-psychiatrist, tele-psychologist, tele-pharmacist, and tele-nurse care manager) and will use telemedicine technologies (telephone, interactive video and electronically shared medical records) to treat CBOC patients with a newly emerging or chronic PTSD. We hypothesize that study participants randomized to the TOP intervention will receive higher quality of care and experience better outcomes compared to study participants randomized to treatment as usual.


Options:
A: Arm Label: REP + EF; Type: EXPERIMENTAL; Interventions: Behavioral: External Facilitation | Arm Label: REP + EF/IF; Type: EXPERIMENTAL; Interventions: Behavioral: External + Internal Facilitation | Intervention Type: BEHAVIORAL; Name: External Facilitation; Assigned to Arm(s): REP + EF | Intervention Type: BEHAVIORAL; Name: External + Internal Facilitation; Assigned to Arm(s): REP + EF/IF
B: Arm Label: Standardized SMA; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standardized SMA | Arm Label: Patient-driven SMA; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Patient-driven SMA | Intervention Type: BEHAVIORAL; Name: Standardized SMA; Assigned to Arm(s): Standardized SMA | Intervention Type: BEHAVIORAL; Name: Patient-driven SMA; Assigned to Arm(s): Patient-driven SMA
C: Arm Label: Arm 1 Telemedicine Outreach for PTSD; Type: EXPERIMENTAL; Interventions: Other: Telemedicine Outreach for PTSD | Arm Label: Arm 2 Treatment as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Telemedicine Outreach for PTSD; Assigned to Arm(s): Arm 1 Telemedicine Outreach for PTSD
D: Arm Label: Arm 1 - Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Arm 2 - Life Goals Collaborative Care; Type: EXPERIMENTAL; Interventions: Behavioral: Life Goals Collaborative Care | Intervention Type: BEHAVIORAL; Name: Life Goals Collaborative Care; Assigned to Arm(s): Arm 2 - Life Goals Collaborative Care

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Amager Project. Intervention After Suicide Attempt: A Randomized Study.
Brief Summary: Background:

Repetition rate after a suicide attempt and self harm is very high, about 12-30 percent. Studies, reviewed by Hawton, 1999 show a lack of evidence for psychosocial interventions. Compliance with aftercare is also often very poor.

Objective:

Inspired by the Norwegian Baerum project, the aim is to study if active, assertive outreach, seeking contact, talking about problem solution, motivate to comply to other appointments, will reduce repetition of suicidal acts in the following years.

Methods:

The design is a prospective randomized, controlled trial. The patients (immediately after a suicide attempt or deliberate self harm)) included are randomized to intervention or standard (treatment as usual), aiming at at least 60 persons in each arm. The intervention is carried out through research nurses with about 8 home visits, phone contact, phone messaging, e-mails.Included are persons 12 years of age and older, danish speaking without translator and without diagnoses of severe mental illness (schizophrenia, bipolar illness, mania and severe/psychotic depression) or severe dementia.

Results:

Outcome is measured by repetition of suicidal act (suicide attempt, self harm or completed suicide)as recorded in medical records and by the Danish Cause of Death Register. Repetition measured by persons and by acts throughout 1 year, 2 and 3 years periods. Additional outcome is number and character of health system contacts.


Options:
A: Arm Label: Dialectical Behavior Therapy DBT; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: DBT | Arm Label: CAMS; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: CAMS | Intervention Type: BEHAVIORAL; Name: DBT; Assigned to Arm(s): Dialectical Behavior Therapy DBT | Intervention Type: BEHAVIORAL; Name: CAMS; Assigned to Arm(s): CAMS
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: OPAC (Outreach, Problem solving, Adherence, Continuity) | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: OPAC (Outreach, Problem solving, Adherence, Continuity); Assigned to Arm(s): 1
C: Arm Label: Teachable Moment Brief Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Teachable Moment Brief Intervention (TMBI) | Arm Label: Treatment as Usual (TAU); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Community Control Group (CCG); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Teachable Moment Brief Intervention (TMBI); Assigned to Arm(s): Teachable Moment Brief Intervention
D: Arm Label: CAMS treatment; Type: EXPERIMENTAL; Interventions: Behavioral: Psychotherapy | Arm Label: Treatment as usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Psychotherapy | Intervention Type: BEHAVIORAL; Name: Psychotherapy; Assigned to Arm(s): CAMS treatment, Treatment as usual

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prospective Randomised Controlled Trial of Video-Assisted Thoracoscopic (VAT) Cytoreductive Pleurectomy Compared to Talc Pleurodesis in Patients With Suspected or Proven Malignant Mesothelioma
Brief Summary: RATIONALE: Video-assisted surgery to remove part of the tissue layer covering the inside of the chest cavity may be effective in treating pleural effusion and cause less damage to normal tissue. Talc pleurodesis may keep fluid from building up in the chest cavity. It is not yet known which therapy is more effective in treating pleural effusion caused by malignant mesothelioma.

PURPOSE: This randomized phase III trial is studying video-assisted surgery to see how well it works compared with talc pleurodesis in treating patients with malignant mesothelioma.


Options:
A: Arm Label: EDIT Management; Type: EXPERIMENTAL; Interventions: Procedure: EDIT Management | Arm Label: Standard Care; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Chest drain and talc pleurodesis | Intervention Type: PROCEDURE; Name: EDIT Management; Assigned to Arm(s): EDIT Management | Intervention Type: PROCEDURE; Name: Chest drain and talc pleurodesis; Assigned to Arm(s): Standard Care
B: Arm Label: Arm I; Type: EXPERIMENTAL; Interventions: Procedure: therapeutic videothoracoscopy | Arm Label: Arm II; Type: ACTIVE_COMPARATOR; Interventions: Other: talc, Procedure: therapeutic thoracoscopy | Intervention Type: OTHER; Name: talc; Assigned to Arm(s): Arm II | Intervention Type: PROCEDURE; Name: therapeutic thoracoscopy; Assigned to Arm(s): Arm II | Intervention Type: PROCEDURE; Name: therapeutic videothoracoscopy; Assigned to Arm(s): Arm I
C: Arm Label: pleurectomy/decortication; Type: EXPERIMENTAL; Interventions: Procedure: pleurectomy/decortication | Arm Label: indwelling pleural catheter; Type: EXPERIMENTAL; Interventions: Procedure: indwelling pleural catheter | Intervention Type: PROCEDURE; Name: pleurectomy/decortication; Assigned to Arm(s): pleurectomy/decortication | Intervention Type: PROCEDURE; Name: indwelling pleural catheter; Assigned to Arm(s): indwelling pleural catheter
D: Arm Label: 1. Videothoracoscopic talc poudrage (VT); Type: ACTIVE_COMPARATOR; Interventions: Procedure: Videothoracoscopic talc poudrage (VT). | Arm Label: 2. Talc slurry through a chest tube (DT); Type: ACTIVE_COMPARATOR; Interventions: Procedure: Talc slurry through a chest tube (DT). | Intervention Type: PROCEDURE; Name: Videothoracoscopic talc poudrage (VT).; Assigned to Arm(s): 1. Videothoracoscopic talc poudrage (VT) | Intervention Type: PROCEDURE; Name: Talc slurry through a chest tube (DT).; Assigned to Arm(s): 2. Talc slurry through a chest tube (DT)

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Brief Summary: The purpose of this study is to see how safe and effective L carnitine taken with cilostazol is compared to placebo taken with cilostazol for people with intermittent claudication. A second purpose of the study is to see if L-carnitine is absorbed into the blood stream.


Options:
A: Arm Label: Cilostazol; Type: EXPERIMENTAL; Interventions: Drug: cilostazol | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: cilostazol; Assigned to Arm(s): Cilostazol | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Person-centered follow up; Type: EXPERIMENTAL; Interventions: Behavioral: Person-centered follow up | Arm Label: Standard follow up; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Person-centered follow up; Assigned to Arm(s): Person-centered follow up
C: Arm Label: low dose K-134; Type: EXPERIMENTAL; Interventions: Drug: K-134 | Arm Label: mid dose K-134; Type: EXPERIMENTAL; Interventions: Drug: K-134 | Arm Label: high dose K-134; Type: EXPERIMENTAL; Interventions: Drug: K-134 | Arm Label: Comparator; Type: ACTIVE_COMPARATOR; Interventions: Drug: Cilostazol 100 mg BID | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: K-134; Assigned to Arm(s): high dose K-134, low dose K-134, mid dose K-134 | Intervention Type: DRUG; Name: Cilostazol 100 mg BID; Assigned to Arm(s): Comparator | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Cilostazol + L-Carnitine; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Levocarnitine tartrate, Drug: cilostazol | Arm Label: Cilostazol + Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: cilostazol | Intervention Type: DIETARY_SUPPLEMENT; Name: Levocarnitine tartrate; Assigned to Arm(s): Cilostazol + L-Carnitine | Intervention Type: DRUG; Name: cilostazol; Assigned to Arm(s): Cilostazol + L-Carnitine, Cilostazol + Placebo

Answer: D